Alaethes Wealth LLC Bristol Myers Squibb CO Transaction History

Alaethes Wealth LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $483,206 - $547,862	10,071 Added 58.58%	27,263 $1.48 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $29,815 - $35,577	-615 Reduced 3.45%	17,192 $882,000
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $139,399 - $155,869	2,408 Added 15.64%	17,807 $1.03 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $38,226 - $42,444	600 Added 4.05%	15,399 $984,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $83,385 - $94,578	1,269 Added 9.38%	14,799 $1.03 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $50,195 - $59,438	733 Added 5.73%	13,530 $973,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $1,663 - $983,321	12,797 New	12,797 $910,000
Q2 2022 Aug 16, 2022	SELL	$72.62 - $79.98 $1,742 - $1,919	-24 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $1,475 - $1,769	-24 Reduced 50.0%	24 $2,000
Q2 2021 Aug 13, 2021	BUY	$61.91 - $67.42 $2,971 - $3,236	48 New	48 $3,000

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Alaethes Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Alaethes Wealth LLC with notifications on news.